# FDA recall D-0600-2021

> **Boehringer Ingelheim Pharmaceuticals, Inc.** · Class II · drug recall initiated 2021-05-04.

## Product

Micardis Tablets, (telmisartan Tablets) 80 mg, 30 ct. per folding cartons, Rx only, NDC 0597-0041-37), Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877

## Reason for recall

Subpotent Drug

## Distribution

AR, CO, CT, LA, NC, ND, NH, NJ, OH, PA and PR

## Key facts

- **Recall number:** D-0600-2021
- **Recalling firm:** Boehringer Ingelheim Pharmaceuticals, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-05-04
- **Report date:** 2021-06-09
- **Termination date:** 2021-10-14

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Ridgefield, CT, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0600-2021

## Citation

> AI Analytics. FDA recall D-0600-2021. Retrieved 2026-06-10 from https://api.ai-analytics.org/recall/D-0600-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*